These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome. Jovani M; Fiorino G; Danese S Aliment Pharmacol Ther; 2013 Jan; 37(2):277-8. PubMed ID: 23252779 [No Abstract] [Full Text] [Related]
3. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Matricon J; Meleine M; Gelot A; Piche T; Dapoigny M; Muller E; Ardid D Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1009-31. PubMed ID: 23066886 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of irritable bowel syndrome: the mast cell connection. Santos J; Guilarte M; Alonso C; Malagelada JR Scand J Gastroenterol; 2005 Feb; 40(2):129-40. PubMed ID: 15764142 [No Abstract] [Full Text] [Related]
5. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. Martin-Viñas JJ; Quigley EM J Dig Dis; 2016 Sep; 17(9):572-581. PubMed ID: 27426409 [TBL] [Abstract][Full Text] [Related]
6. The role of mast cells in functional GI disorders. Wouters MM; Vicario M; Santos J Gut; 2016 Jan; 65(1):155-68. PubMed ID: 26194403 [TBL] [Abstract][Full Text] [Related]
7. [The irritable bowel syndrome, should not be considered a functional disorder?]. Sebastián Domingo JJ Med Clin (Barc); 2013 May; 140(9):403-5. PubMed ID: 23337457 [No Abstract] [Full Text] [Related]
8. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358 [TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome immune hypothesis. Part one: the role of lymphocytes and mast cells. Ortiz-Lucas M; Saz-Peiró P; Sebastián-Domingo JJ Rev Esp Enferm Dig; 2010 Nov; 102(11):637-47. PubMed ID: 21142384 [TBL] [Abstract][Full Text] [Related]
10. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies. Wood JD Gut; 2006 Apr; 55(4):445-7. PubMed ID: 16531524 [TBL] [Abstract][Full Text] [Related]
11. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model. Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992 [TBL] [Abstract][Full Text] [Related]
12. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080 [TBL] [Abstract][Full Text] [Related]
13. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818 [TBL] [Abstract][Full Text] [Related]
14. Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Barbara G Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952 [TBL] [Abstract][Full Text] [Related]
15. [Stress-mast cell axis and regulation of gut mucosal inflammation: from intestinal health to an irritable bowel]. Ramos L; Vicario M; Santos J Med Clin (Barc); 2007 Jun; 129(2):61-9. PubMed ID: 17588364 [TBL] [Abstract][Full Text] [Related]
16. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Boyer J; Saint-Paul MC; Dadone B; Patouraux S; Vivinus MH; Ouvrier D; Michiels JF; Piche T; Tulic MK Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 28975689 [TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome and the elusive mast cells. Theoharides TC; Asadi S; Chen J; Huizinga JD Am J Gastroenterol; 2012 May; 107(5):727-9. PubMed ID: 22552242 [TBL] [Abstract][Full Text] [Related]
19. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380 [TBL] [Abstract][Full Text] [Related]
20. Atopic irritable bowel syndrome: same old hat or a new entity? Tobin MC; Keshavazian A; Farhardi A Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):457-9. PubMed ID: 19072394 [No Abstract] [Full Text] [Related] [Next] [New Search]